Skip to main content
  • Safe and Effective Management of Antiplatelet Therapy in a Clopidogrel-Naive Patient Undergoing “Ad Hoc” Complex Coronary Intervention: A Case Report

    Abstract

    Background

    “Ad hoc” percutaneous coronary intervention (PCI) is a frequent practice as reported in large real-life registries, but most of the patients undergo PCI without being on full and effective dual antiplatelet therapy or clopidogrel is administered orally only a few minutes before the beginning of the procedure. This practice, especially in complex PCI, could be affected by a higher rate of peri-procedural adverse events.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details